Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.
Press releases published on April 22, 2025

Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference
CHASKA, Minn., April 22, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the upcoming CDMO …

FundThrough Acquires Ampla, Strengthening its Digital-First Invoice Funding Solution
HOUSTON and TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- FundThrough, the leading fintech invoice factoring platform for small and medium-sized businesses (SMBs), today announced its acquisition of Ampla, the leading provider of financial technology …

Axonius Launches Exposures – A Breakthrough Product to Unify Security, Asset, and Business Context in a Single Platform
NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- Axonius, the leader in cyber asset management that delivers visibility and actionability across all digital assets, today announced the launch of Axonius Exposures, a groundbreaking solution that transforms Risk …

PolyPid to Participate in The Citizens Life Sciences Conference
PETACH TIKVA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that the Company’s management will participate in a …

Best Retargeting Ads Platform (2025): Meta Pixel Recognized As Top Ad Retargeting Solution by Software Experts
NEW YORK CITY, April 22, 2025 (GLOBE NEWSWIRE) -- Software Experts has recognized Meta Pixel as a top solution for ad retargeting, emphasizing its role in helping businesses optimize ad performance and improve conversion rates. Top Ad Retargeting Platform …

Kymera Therapeutics Announces First Patient Dosed in BROADEN Phase 1b Atopic Dermatitis Clinical Trial of KT-621, a First-in-Class Oral STAT6 Degrader
Data from the BroADen Phase 1b atopic dermatitis (AD) patient trial expected to be reported in 4Q25 Completed SAD/MAD dosing in KT-621 Phase 1 healthy volunteer trial with data to be reported in June 2025 Two parallel Phase 2b trials in AD and asthma …

InStride’s Hybrid Clinical Cohorts Fill High-Need Roles in Healthcare
LOS ANGELES, April 22, 2025 (GLOBE NEWSWIRE) -- InStride, a human capital management company providing strategic education benefits, today announced a hybrid education model that empowers healthcare organizations to fill critical roles by developing talent …

Orchestra BioMed Receives FDA Breakthrough Device Designation for AVIM Therapy
Breakthrough Device Designation (“BDD”) applies to an estimated U.S. population of over 7.7 million patients with uncontrolled hypertension and increased cardiovascular risk BDD also encompasses pacemaker-indicated patients with uncontrolled hypertension …

Rapport Therapeutics to Participate in Upcoming Investor Conferences
BOSTON and SAN DIEGO, April 22, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for …

Medicenna to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
TORONTO and HOUSTON, April 22, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune …

Voice2Me.ai Launches Ultra-Secured AI Voice Agents Intelligence Platform for ServiceNow
Fairfax, Virginia, April 22, 2025 (GLOBE NEWSWIRE) -- Voice2Me.ai officially announces the launch of the industry’s first ultra-secured AI voice agents intelligence platform, now available for ServiceNow clients. The platform introduces a ServiceNow-native …

DN Miner Unveils Next-Generation Mining Infrastructure with Enhanced Security and Performance
London, UK, April 22, 2025 (GLOBE NEWSWIRE) -- DN Miner, a leading cryptocurrency mining service provider certified by the UK Financial Conduct Authority (FCA), today announced major upgrades to its cloud mining infrastructure, marking a significant …

Aclaris Therapeutics Secures U.S. Food and Drug Administration IND Clearance for ATI-052, Enabling Advancement of its Novel Bispecific Anti-TSLP/IL-4R Investigational Antibody
- Initiation of Upcoming Phase 1a/1b Clinical Trial Expected in the Second Quarter of 2025 - WAYNE, Pa, April 22, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel …

Arch Biopartners Announces Toronto General Hospital Ethics Board Approval to Join the Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI)
TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the University Health Network (UHN) Research Ethics Board has granted approval for Toronto General …

RentRedi Launches “Chat 2.0” to Enhance Landlord-Tenant Communication
NEW YORK, April 22, 2025 (GLOBE NEWSWIRE) -- RentRedi, the fastest-growing all-in-one property management software that makes renting easy for both landlords and renters, has launched Chat 2.0, a robust new in-app messaging feature designed to enhance …

BioNTech veröffentlicht am 5. Mai 2025 Ergebnisse für das erste Quartal 2025 und informiert über operativen Fortschritt
MAINZ, Deutschland, 22. April 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird am Montag, den 5. Mai 2025, die Ergebnisse für das erste Quartal 2025 veröffentlichen. Darüber hinaus wird das Unternehmen am selben …

BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025
MAINZ, Germany, April 22, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2025 on Monday, May 5, 2025. Additionally, the Company will host a conference call and …

Intelagen and Unframe Partner for Rapid Enterprise AI Solutions
Saint Petersburg, FL, April 22, 2025 (GLOBE NEWSWIRE) -- Intelagen, a leading Google Cloud Partner and AI consultancy, today announced a partnership with Unframe, the all-in-one turnkey AI platform for global enterprises. The partnership will initially …

BEN Launches “iSKYE” AI Platform
WILMINGTON, Del., April 22, 2025 (GLOBE NEWSWIRE) -- Brand Engagement Network Inc. (BEN) (Nasdaq: BNAI), a global innovator in AI-driven customer engagement solutions, announces the Generally Available (GA) release of its iSKYE platform to enable …

AscellaHealth Demonstrates Leadership in Realizing the Full Potential of Novel Therapies and Medicinal Products at Advanced Therapies Integrates North 2025
DUBLIN and BERWYN, Pa., April 22, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customisable solutions to support the specialty pharmaceutical industry, proudly announces its participation in Advanced Therapies Integrates North 2025, …